• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A rating scale for acute drug-induced akathisia: development, reliability, and validity.

作者信息

Sachdev P

机构信息

Neuropsychiatric Institute, Prince Henry Hospital, Sydney, Australia.

出版信息

Biol Psychiatry. 1994 Feb 15;35(4):263-71. doi: 10.1016/0006-3223(94)91257-2.

DOI:10.1016/0006-3223(94)91257-2
PMID:7910487
Abstract

This paper describes the process of developing a new rating scale for acute neuroleptic-induced akathisia. Previously reported clinical characteristics of akathisia were used to construct the initial version of the scale. This was administered to 100 consecutively admitted psychiatric patients treated with neuroleptic medication. The scale was then subjected to a reliability analysis, and the number of items reduced. A factor analysis of the ratings supported the decision to rate subjective and objective items separately. The new version of the scale (The Prince Henry Hospital Akathisia Rating Scale) was further standardized in its administration. A preliminary examination of its construct validity was performed by calculating the correlations with the ratings on the analogue and global scales, as well as those of depression, anxiety, and hyperactivity. The new scale was administered to 50 new subjects to examine its interrater reliability and concurrent validity with respect to the Barnes Akathisia Rating Scale.

摘要

相似文献

1
A rating scale for acute drug-induced akathisia: development, reliability, and validity.
Biol Psychiatry. 1994 Feb 15;35(4):263-71. doi: 10.1016/0006-3223(94)91257-2.
2
The Barnes Akathisia Rating Scale--revisited.巴恩斯静坐不能评定量表——再探讨。
J Psychopharmacol. 2003 Dec;17(4):365-70. doi: 10.1177/0269881103174013.
3
Assessment of extrapyramidal symptoms during acute neuroleptic treatment.急性抗精神病药物治疗期间锥体外系症状的评估。
J Clin Psychiatry. 1995 Mar;56(3):94-100.
4
[Subjective experiences of patients with acute neuroleptic-induced akathisia].[急性抗精神病药物所致静坐不能患者的主观体验]
Fortschr Neurol Psychiatr. 1998 Dec;66(12):531-8. doi: 10.1055/s-2007-995295.
5
Akathisia in adults with mental retardation: development of the Akathisia Ratings of Movement Scale (ARMS).成年智力障碍者的静坐不能:静坐不能运动评定量表(ARMS)的开发。
Am J Ment Retard. 1997 Jan;101(4):413-23.
6
Clinical characteristics and predisposing factors in acute drug-induced akathisia.
Arch Gen Psychiatry. 1994 Dec;51(12):963-74. doi: 10.1001/archpsyc.1994.03950120035007.
7
Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia.用于抗精神病药物所致静坐不能的活动测量法和巴恩斯静坐不能评定量表
Eur Neuropsychopharmacol. 2005 Jan;15(1):39-41. doi: 10.1016/j.euroneuro.2004.05.003.
8
Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.药物性锥体外系症状量表(DIEPSS)的计量学特征:一种用于药物性运动障碍的实用综合评定量表。
Mov Disord. 2002 Nov;17(6):1354-9. doi: 10.1002/mds.10255.
9
[Effect of activation tasks on acute neuroleptic-induced akathisia].[激活任务对急性抗精神病药物所致静坐不能的影响]
Nervenarzt. 2000 Jan;71(1):30-7. doi: 10.1007/s001150050004.
10
Cyproheptadine treatment in neuroleptic-induced akathisia.赛庚啶治疗抗精神病药所致静坐不能
Br J Psychiatry. 1995 Oct;167(4):483-6. doi: 10.1192/bjp.167.4.483.

引用本文的文献

1
Remission of Gilles de la Tourette Syndrome after Heat-Induced Dehydration.热诱导脱水后抽动秽语综合征的缓解
Int J Phys Med Rehabil. 2018;6(3). doi: 10.4172/2329-9096.1000472. Epub 2018 Jun 13.
2
Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.结合调节因素来确定哪些抗药性老年重度抑郁症患者会从阿立哌唑增效治疗中获益,哪些不会。
J Psychiatr Res. 2016 Oct;81:112-8. doi: 10.1016/j.jpsychires.2016.07.005. Epub 2016 Jul 7.
3
Antipsychotic-induced akathisia in delirium: A systematic review.
谵妄中抗精神病药物所致静坐不能:一项系统评价。
Palliat Support Care. 2016 Feb;14(1):77-84. doi: 10.1017/S1478951515000784. Epub 2015 Jun 19.
4
The Tolerability of Mirtazapine Augmentation in Schizophrenic Patients Treated with Risperidone: A Preliminary Randomized Placebo-controlled Trial.米氮平增效治疗利培酮治疗的精神分裂症患者的耐受性:一项初步的随机安慰剂对照试验。
Clin Psychopharmacol Neurosci. 2011 Aug;9(2):73-7. doi: 10.9758/cpn.2011.9.2.73. Epub 2011 Aug 31.
5
Positron emission tomography experience with 2-[¹⁸F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[¹⁸F]FA) in the living human brain of smokers with paranoid schizophrenia.正电子发射断层扫描技术在吸烟的偏执型精神分裂症患者活体大脑中 2-[¹⁸F]氟-3-(2(S)-氮杂环丁烷甲氧基)吡啶(2-[¹⁸F]FA)的应用经验。
Synapse. 2012 Apr;66(4):352-68. doi: 10.1002/syn.21520. Epub 2011 Dec 29.
6
Antipsychotic-induced movement disorders: evaluation and treatment.抗精神病药物所致运动障碍:评估与治疗
Psychiatry (Edgmont). 2005 Mar;2(3):36-41.
7
Intravenous administration of metoclopramide by 2 min bolus vs 15 min infusion: does it affect the improvement of headache while reducing the side effects?静脉注射甲氧氯普胺时,2分钟推注与15分钟输注相比:在减少副作用的同时,它是否会影响头痛的改善?
Postgrad Med J. 2007 Oct;83(984):664-8. doi: 10.1136/pgmj.2007.057570.
8
Rate of metoclopramide infusion affects the severity and incidence of akathisia.甲氧氯普胺的输注速度会影响静坐不能的严重程度和发生率。
Emerg Med J. 2005 Sep;22(9):621-4. doi: 10.1136/emj.2004.014712.
9
Research diagnostic criteria for drug-induced akathisia: conceptualization, rationale and proposal.药物性静坐不能的研究诊断标准:概念化、基本原理及建议。
Psychopharmacology (Berl). 1994 Feb;114(1):181-6. doi: 10.1007/BF02245462.